GW&K Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

GW&K Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-447	Closed	-$42K	–	859
2021 Q4	$42K	Sell	447 -129,802	-100%	-$8.55M	﹤0.01%	361
2021 Q3	$7.76M	Buy	130,249 +23,300	+22%	+$1.38M	0.07%	229
2021 Q2	$7.29M	Sell	106,949 -1,854	-2%	-$121K	0.06%	241
2021 Q1	$7.55M	Buy	108,803 +5,906	+6%	+$454K	0.07%	231
2020 Q4	$7.91M	Sell	102,897 -2,488	-2%	-$186K	0.08%	228
2020 Q3	$7.88M	Sell	105,385 -1,803	-2%	-$120K	0.1%	222
2020 Q2	$6.75M	Sell	107,188 -28,240	-21%	-$1.55M	0.09%	224
2020 Q1	$5.69M	Buy	135,428 +15,065	+13%	+$691K	0.1%	210
2019 Q4	$5.47M	Buy	+120,363	New	+$5.69M	0.07%	235

GW&K Investment Management's ARNA Position: Q1 2022 in Review

GW&K Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 447 shares — an estimated $42K sold.

GW&K Investment Management first reported a position in ARNA in Q4 2019 and held it in 9 quarters. The position peaked at $7.91M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

GW&K Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
GW&K Investment Management sold 447 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $42K.
GW&K Investment Management first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 9 quarters.
GW&K Investment Management's Arena Pharmaceuticals Inc position peaked at $7.91M in Q4 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on GW&K Investment Management's 13F filing for Q1 2022, filed 9 May 2022.